Vendor, Philadelphia, PA, part of Glaxosmithkline PLC
Glaxosmithkline Holdings (Americas) Inc.
UEI QQH9KHXNCG81, CAGE 93544
3 awards and -$5,525,797 obligated between January 8, 2025 and January 9, 2025, 33% under full and open competition, against 3.3 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | -$5,525,797 |
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | -$1 |
| Biological Product (except Diagnostic) ManufacturingNAICS 325414 | -$5,525,796 |
How it wins
Awards by competition, set-aside and type.
| Not Competed | 2 |
| Full and Open Competition | 1 |
| Definitive Contract | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HHSO100200900123CDefinitive Contract, January 9, 2025, Not Competed, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Close Contract and Deobligate .60NAICS 325412, PSC 6505 | -$1 |
| HHSO100200600016IJanuary 8, 2025, Not Competed, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Deobligation of Excess FundsNAICS 325414, PSC 6505 | -$1,303,449 |
| HHSO100200600011CDefinitive Contract, January 8, 2025, Full and Open Competition, 8 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Contract Closeout Deobligate Excess FundsNAICS 325414, PSC 6505 | -$4,222,347 |
- Places of performance
- Pennsylvania
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 3 across 3 awards